Article: FDA Approves Once-Daily Veramyst(TM) (fluticasone furoate) Nasal Spray for Treatment of Seasonal and Year-Round Allergy Symptoms in Adults and Children as Young as Two Years

To: MEDICAL EDITORS

Contact: US Media inquiries, Holly Russell, 919-483-2839, or Mary Anne Rhyne, 919-483-2839; or UK Media inquiries, Phil Thomson (020) 8047 5502, Joss Mathieson,(020) 8047 5502, or Gwenan White, (020) 8047 5502; or US Analyst-Investor inquiries, Frank Murdolo, 215-751- 7002, or Tom Curry 215-751-5419; or European Analyst-Investor inquiries, Anita Kidgell,(020) 8047 5542, David Mawdsley, (020) 8047 5564, or Sally Ferguson, (020) 8047 5543

RESEARCH TRIANGLE PARK, N.C., April 30 /PRNewswire/ -- The U.S. Food and Drug Administration approved once-daily Veramyst(TM) (fluticasone furoate) Nasal Spray on Friday to treat seasonal and year-round allergy symptoms in adults and ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!